ARALEZ PHARMACEUTICALS INC. Payment for Contingent Consideration Liability, Operating Activities
ARALEZ PHARMACEUTICALS INC. reported Payment for Contingent Consideration Liability, Operating Activities of $158.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities · last filed 2017-11-09
- ARALEZ PHARMACEUTICALS INC. payment for contingent consideration liability, operating activities for the quarter ending 2017-09-30 was -$51.00K.
| Period end | Payment for Contingent Consideration Liability, Operating Activities 3 month | Payment for Contingent Consideration Liability, Operating Activities 6 month | Payment for Contingent Consideration Liability, Operating Activities 9 month |
|---|---|---|---|
| 2017-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $158.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $209.00K 10-Q · filed 2017-08-09 |